Stay updated on ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record history remains unchanged.SummaryDifference0.0%

- Check20 days agoChange DetectedA sitewide NIH notice announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and provides a link to updates and FAQs.SummaryDifference0.3%

- Check27 days agoChange DetectedThe ClinicalTrials.gov footer now displays software revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check34 days agoChange DetectedThe ClinicalTrials.gov site footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check55 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, replacing the previous revision v3.6.6. This reflects an updated version of the record in the history log.SummaryDifference0.0%

- Check76 days agoChange DetectedA new revision entry, v3.6.6, was added to the study's history and the prior revision v3.6.5 was removed, updating the record timeline. This update relates to historical record maintenance rather than substantive changes to the trial content.SummaryDifference0.0%

Stay in the know with updates to ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.